MetadataShow full item record
JournalClinical Infectious Diseases
AbstractIn 2017, the World Health Organization (WHO) published guidelines for the management of advanced human immunodeficiency virus (HIV) disease within a public health approach. Recent data suggest that more than a third of people starting antiretroviral therapy (ART) do so with advanced HIV disease, and an increasing number of patients re-present to care at an advanced stage of HIV disease following a period of disengagement from care. These guidelines recommend a standardized package of care for adults, adolescents, and children, based on the leading causes of morbidity and mortality: tuberculosis, severe bacterial infections, cryptococcal meningitis, toxoplasmosis, and Pneumocystis jirovecii pneumonia. A package of targeted interventions to reduce mortality and morbidity was recommended, based on results of 2 recent randomized trials that both showed a mortality reduction associated with delivery of a simplified intervention package. Taking these results and existing recommendations into consideration, WHO recommends that a package of care be offered to those presenting with advanced HIV disease; depending on age and CD4 cell count, the package may include opportunistic infection screening and prophylaxis, including fluconazole preemptive therapy for those who are cryptococcal antigen positive and without evidence of meningitis. Rapid ART initiation and intensified adherence interventions should also be proposed to everyone presenting with advanced HIV disease.
PublisherOxford University Press
- Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
- Authors: Eshun-Wilson I, Okwen MP, Richardson M, Bicanic T
- Issue date: 2018 Jul 24
- Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
- Authors: Benzekri NA, Sambou JF, Ndong S, Tamba IT, Faye D, Diallo MB, Diatta JP, Faye K, Sall I, Sall F, Manga NM, Malomar JJ, Ndour CT, Hawes SE, Seydi M, Gottlieb GS
- Issue date: 2019 Mar 15
- Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
- Authors: Njei B, Kongnyuy EJ, Kumar S, Okwen MP, Sankar MJ, Mbuagbaw L
- Issue date: 2013 Feb 28
- Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.
- Authors: Kendi C, Penner J, Koech J, Nyonda M, Cohen CR, Bukusi EA, Ngugi E, Meyer AC
- Issue date: 2013 Feb
- Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.
- Authors: Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N, Govender NP, Bekker LG, Wood R, Harrison TS
- Issue date: 2016 Mar 1